Program
Course overview
This training course aims at promoting an integrated technology in carbon-ion radiotherapy, providing basic knowledge and practice-oriented trainings concerning carbon-ion radiotherapy as well as other topics related to this field.
Target Group
This training course is targeted primarily at participants with some expertise in radiotherapy and those who are interested in carbon-ion radiotherapy. Not only that, but also, trainees in radiotherapy, radiation oncologists, medical physicists, radiation biologists, radiological technologists, and any individuals having interests in this field.
Program (Tentative)
Introduction
1 | Lessons from the history of particle therapy | Hirohiko Tsujii | QST * |
2 | J-CROS activities | Hiroshi Tsuji | QST * |
3 | Cost effectiveness of CIRT | Tatsuya Ohno | Gunma University |
Biology
1 | Characteristics of Carbon Ion Radiotherapy in cancer therapy | Marco Durante | GSI Helmholtzzentrum für Schwerionenforschung |
2 | Hypoxia in Carbon Ion radiotherapy | Ryoichi Hirayama | QST * |
3 | Anti-tumor immunity induced by heavy-ion / photon radiotherapy |
Tsuguhide Takeshima | QST * |
4 | Biological effects of fractionation | Yukari Yoshida | Gunma University |
5 | Precision Carbon Ion Radiotherapy | Takahiro Oike | Gunma University |
6 | Radiation and Risk of Cancer | Tatsuhiko Imaoka | QST * |
7 | Targeted Cancer Therapy using Radioisotopes | Sumitaka Hasegawa | QST * |
8 | Biological Aspects of FLASH Particle Therapy | Teruaki Konishi | QST * |
9 | Implementation of immuno-radiotherapy -from a radiation oncologist’s point of view- |
Noriyuki Okonogi | QST * |
Physics
1 | Accelerators for CIRT and Quantum Scalpel | Yoshiyuki Iwata | QST * |
2 | Beam delivery, QA (inc. J-CROS) | Hideyuki Mizuno | QST * |
3 | Biological models (inc. Multi-ion/FLASH) | Taku Inaniwa | QST * |
4 | Treatment planning and range uncertainty in carbon-ion radiotherapy | Nobuyuki Kanematsu | QST * |
5 | Motion management & IGRT with in-room CT | Makoto Sakai | Gunma University |
6 | Facility commissioning at Osaka-HIMAK | Masaaki Takashina | OSAKA HIMAK |
7 | Facility commissioning at Yamagata | Hikaru Souda | Yamagata University |
8 | Facility design of Yonsei Cancer Center Korea | Jin Sung Kim | Yonsei Cancer Center |
9 | Facility design of Mayo Clinic | Keith Furutani | Mayo Clinic |
10 | What Particle Therapy Can Learn from IMRT and Other High- Precision Radiotherapies |
Arnold Pompos | UT Southwestern Medical Center |
Clinical aspects
1 | Head & Neck Tumor | Masashi Koto | QST * |
2 | Eye Tumor | Masaru Wakatsuki | QST * |
3 | Lung Cancer | Mio Nakajima | QST * |
4 | Liver Cancer | Kei Shibuya | Gunma University |
5 | Pancreas Cancer | Makoto Shinoto | QST * |
6 | Bone & Soft tissue Sarcoma | Reiko Imai | QST * |
7 | Urological Cancer | Motohiro Murakami | QST * |
8 | Locally Recurrent Colorectal Cancer | Hirotoshi Takiyama | QST * |
9 | Gynecological Cancer | Kazutoshi Murata | QST * |
10 | Breast Cancer | Yasumasa Mori | QST * |
Diagnosis
1 | Diagnostic PET imaging for CIRT | Ryuichi Nishii | QST * |
2 | ACR Reporting and Data System (RADS) - Essential for treatment of lung, liver and prostate cancer - |
Riwa Kishimoto | QST * |
Topics
1 | History of particle beam therapy in Japan from the perspective of national health policy |
Hideyuki Sakurai | Tsukuba University |
2 | Rationale and Indications for CIRT at Mayo Clinic USA | Robert L. Foote | Mayo Clinic |
3 | Reducing Toxicity and Lowering Cost with Particle Therapy | Robert L. Foote | Mayo Clinic |
4 | Overview of BNCT & Current status of Accelerated-based BNCT |
Yoshihiro Takai | Southern Tohoku BNCT Research Center |
5 | Radiation Emergency Medicine | Hideo Tatsuzaki | QST * |
6 | Risk Communication: Communicating with the Public about Radiation |
Tomoaki Tamaki | Fukushima Medical University |
Overview - Clinical aspect of facilities
‐ Overseas facilities
1 | The experience with studies of protons versus carbon ion radiotherapy at HIT | Juergen Debus | Heidelberg University Hospital - Germany |
2 | The clinical experience of hadron therapy at CNAO | Ester Orlandi | National Center for Oncological Hadrontherapy - Italy |
3 | The clinical experience of charged particle radiotherapy that has been done at MedAustron | Piero Fossati | EBG MedAustron GmbH - Austria |
‐ Domestic facilities
1 | Introduction of facilities Gunma University Heavy Ion Medical Center (GHMC) |
Hidemasa kawamura | Gunma University Heavy Ion Medical Center(GHMC) |
2 | Clinical aspects of Hyogo Ion Beam Medical Center | Tomoaki Okimoto | Hyogo Ion Beam Medical Center |
3 | Clinical aspects of Carbon-ion Radiotherapy in Kanagawa Cancer Center |
Hiroyuki Katoh | Kanagawa Cancer Center |
4 | Clinical aspects of OSAKA HIMAK | Teruki Teshima | OSAKA HIMAK |
5 | Clinical experience of Carbon Ion Therapy at QST | Shigeru Yamada | QST * |
6 | Carbon-ion Radiotherapy in Saga-HIMAT | Akira Matsunobu | Saga Heavy ion Medical Accelerator in Tosu, Saga HIMAT |
7 | Clinical experience of East Japan Hevy Ion Center | Kenji Nemoto | Yamagata University East Japan Heavy Ion Center |
*Alphabetical order
Introduction of facilities
1 | Gunma University Heavy Ion Medical Center |
2 | Hyogo Ion Beam Medical Center |
3 | Kanagawa Cancer Center |
4 | Osaka Heavy Ion Therapy Center (OSAKA HIMAK) |
5 | QST Hospital, QST * |
6 | Saga Heavy ion Medical Accelerator in Tosu, SagaHIMAT |
7 | Yamagata University East Japan Heavy Ion Center |
*Alphabetical order
Vendor presentation
1 | Hitachi, Ltd. |
2 | RaySearch Laboratories |
3 | Sumitomo Heavy Industries |
4 | Toshiba Corporation |
5 | Alfresa Pharma Corporation |
6 | B dot Medical Inc. |
*) QST : National Institutes for Quantum Science and Technology